Active Ingredient: C1-inhibitor
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE).
For this indication, competent medicine agencies globally authorize below treatments:
Intravenous
500 - 1,000 [iU]
From 500 To 1,000 [iU] once every day
2 to 11 years, >25 kg: 1,000 IU of C1-inhibitor at the first sign of the onset of an acute attack. A second dose of 1,000 IU may be administered if the patient has not responded adequately after 60 minutes.
2 to 11 years, 10-25 kg: 500 IU of C1-inhibitor at the first sign of the onset of an acute attack. A second dose of 500 IU may be administered if the patient has not responded adequately after 60 minutes.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
